MainStreet Investment Advisors LLC Sells 184 Shares of Agilent Technologies, Inc. (NYSE:A)

MainStreet Investment Advisors LLC lowered its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.2% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,613 shares of the medical research company’s stock after selling 184 shares during the period. MainStreet Investment Advisors LLC’s holdings in Agilent Technologies were worth $728,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of A. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies during the fourth quarter worth $26,000. Crewe Advisors LLC increased its holdings in Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. VisionPoint Advisory Group LLC bought a new position in Agilent Technologies in the fourth quarter valued at about $29,000. Ridgewood Investments LLC acquired a new stake in shares of Agilent Technologies during the second quarter valued at about $29,000. Finally, Rise Advisors LLC grew its holdings in shares of Agilent Technologies by 527.8% during the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after purchasing an additional 190 shares during the last quarter. Institutional investors own 87.42% of the company’s stock.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction on Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the transaction, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the sale, the chief executive officer now owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. The disclosure for this sale can be found here. Insiders sold 18,916 shares of company stock worth $2,557,230 over the last three months. 0.33% of the stock is currently owned by insiders.

Agilent Technologies Stock Down 0.8 %

A stock opened at $137.20 on Friday. The stock’s 50 day simple moving average is $135.62 and its 200 day simple moving average is $139.06. The company has a market cap of $40.03 billion, a P/E ratio of 32.43, a price-to-earnings-growth ratio of 6.63 and a beta of 1.05. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the firm earned $1.43 earnings per share. Agilent Technologies’s revenue for the quarter was down 5.6% on a year-over-year basis. On average, research analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on A. Jefferies Financial Group reiterated a “hold” rating and issued a $135.00 price objective (down previously from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. Wolfe Research downgraded shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. Wells Fargo & Company began coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective on the stock. TD Cowen raised their target price on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, Evercore ISI lifted their target price on Agilent Technologies from $130.00 to $135.00 and gave the stock an “in-line” rating in a report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $141.60.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.